Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Jaïs, P; Maury, P; Khairy, P; Sacher, F; Nault, I; Komatsu, Y; Hocini, M; Forclaz, A; Jadidi, AS; Weerasooryia, R; Shah, A; Derval, N; Cochet, H; Knecht, S; Miyazaki, S; Linton, N; Rivard, L; Wright, M; Wilton, SB; Scherr, D; Pascale, P; Roten, L; Pederson, M; Bordachar, P; Laurent, F; Kim, SJ; Ritter, P; Clementy, J; Haïssaguerre, M.
Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia.
Circulation. 2012; 125(18):2184-2196
Doi: 10.1161/CIRCULATIONAHA.111.043216
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Scherr Daniel
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Catheter ablation of ventricular tachycardia (VT) is effective and particularly useful in patients with frequent defibrillator interventions. Various substrate modification techniques have been described for unmappable or hemodynamically intolerable VT. Noninducibility is the most frequently used end point but is associated with significant limitations, so the optimal end point remains unclear. We hypothesized that elimination of local abnormal ventricular activities (LAVAs) during sinus rhythm or ventricular pacing would be a useful and effective end point for substrate-based VT ablation. As an adjunct to this strategy, we used a new high-density mapping catheter and frequently used epicardial mapping. Seventy patients (age, 67±11 years; 7 female) with VT and structurally abnormal ventricle(s) were prospectively enrolled. Conventional mapping was performed in sinus rhythm in all, and a high-density Pentaray mapping catheter was used in the endocardium (n=35) and epicardially. LAVAs were recorded in 67 patients (95.7%; 95% confidence interval, 89.2-98.9). Catheter ablation was performed targeting LAVA with an irrigated-tip catheter placed endocardially via a transseptal or retrograde aortic approach or epicardially via the subxiphoid approach. LAVAs were successfully abolished or dissociated in 47 of 67 patients (70.1%; 95% confidence interval, 58.7-80.1). In multivariate analysis, LAVA elimination was independently associated with a reduction in recurrent VT or death (hazard ratio, 0.49; 95% confidence interval, 0.26-0.95; P=0.035) during long-term follow-up (median, 22 months). LAVAs can be identified in most patients with scar-related VT. Elimination of LAVAs is feasible and safe and is associated with superior survival free from recurrent VT.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Body Surface Potential Mapping - methods
- Catheter Ablation - instrumentation
- Catheter Ablation - methods
- Cicatrix - surgery
- Epicardial Mapping -
- Female -
- Humans -
- Male -
- Middle Aged -
- Reoperation - instrumentation
- Reoperation - methods
- Treatment Outcome -
- Ventricular Fibrillation - mortality
- Ventricular Fibrillation - surgery
- Find related publications in this database (Keywords)
- catheter ablation
- endpoint determination
- epicardial mapping
- tachycardia, ventricular